The kaleidoscope of autoimmunity: Multiple autoimmune syndromes and familial autoimmunity

Expert Review of Clinical Immunology

Volumn 3, Issue 4, 2007, Pages 623-635

  Anaya, Juan Manuel ^a,b   Corena, Rodrigo ^a   Castiblanco, John ^a   Rojas Villarraga, Adriana ^a,b   Shoenfeld, Yehuda ^c,d  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE II; AUTOIMMUNITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY HISTORY; GENDER; HUMAN; INHERITANCE; MEDLINE; MOSAICISM; NUCLEAR FAMILY; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RISK FACTOR; SEX DIFFERENCE; X CHROMOSOME;

EID: 34547104853     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.3.4.623     Document Type: Review

References (96)

1. Anaya JM, Shoenfeld Y, Correa PA, Garcia-Carrasco M, Cervera R. Autoinummity and autoimmune disease. Medellin: CIB (2005).
2. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2, 119-125 (2003).
3. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol. Today 10, 123-126 (1989).
4. Shoenfeld Y, Isenberg DA. Autoimmune diseases - clinical features and animal models. In: The Mosaic of Autoimmunity. Elsevier, NY, USA (1989).
5. Lorber M, Gershwin ME, Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin. Arthritis Rheum. 24, 105-113 (1994).
6. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 15, 245-252 (1993).
7. Weiss P, Shoenfeld Y. Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr. J. Med. Sci. 27, 215-217 (1991).
8. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 85, 311-318 (1996).
9. Sloka S. Observations on recent studies showing increased co-occurrence of autoimmune diseases. J. Autoimmun. 18, 251-257 (2002).
10. Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 17, 202-217 (2006).
11. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349, 1526-1533 (2003).
12. George J, Levy Y, Shoenfeld Y. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand. J. Immunol. 45, 1-6 (1997).
13. Harel M, Shoenfeld Y. Predicting and preventing autoinimunity, myth or reality? Ann. NY Acad. Sci. 1069, 322-345 (2006).
14. Israeli E, Grotto I, Gilburd B et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54, 1232-1236 (2005).
15. Shepshelovich D, Shoenfeld Y. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 15, 183-190 (2006).
16. Sherer Y, Shoenfeld Y. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiology 207, 13-16 (2003).
17. Shoenfeld Y. Primary biliary cirrhosis and autoimmune rheumatic diseases: prediction and prevention. Isr. J. Med. Sci. 28, 113-116 (1992).
18. Shoenfeld Y, Carp HJ, Molina V et al. Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol. 56, 337-344 (2006).
19. Shovman O, Gilburd B, Barzilai O et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/ predictive autoantibodies. Ann. NY Acad. Sci. 1050, 380-388 (2005).
20. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N. Engl. J. Med. 350, 2068-2079 (2004).
21. Anaya JM, Gomez LM, Castiblanco J. Is there a common basis for autoimune diseases? Clin. Dev. Immunol. 13, 185-195 (2006).
22. Humbert P, Dupond JL. Multiple autoimmune syndromes. Ann. Med. Interne (Paris) 139, 159-168 (1988).
23. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16, 90-100 (2003).
24. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J. Neurol. Neurosurg. Psychiatry 65, 492-496 (1998).
25. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. Q. J. Med. 97, 397-406 (2004).
26. Schmidt MB. Eine biglandulare erkrankung (nebennieren und schilddrüse) bei morbus addisonii. Verh. Dtsch Ges. Pathol. 21 (1926).
27. Carpenter CC, Solomon N, Silverberg SG et al. Schmidt's syndrome (thyroid and adrenal insufficiency). A review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine (Balt.) 43, 153-180 (1964).
28. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab. 88, 2983-2992 (2003).
29. Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin. Diagn. Lab. Immunol. 8, 678-685 (2001).
30. Porkodi R, Ramesh S, Mahesh A et al. Thyroid dysfunction in systemic lupus erythemathosus and rheumatoid arthritis. J. Indian Rheumatol. Assoc. 12, 88-90 (2004).
31. Tobon GJ, Arango A, Abad V et al. Clinical and immunological characteristics of Type 1 diabetes mellitus in a northwestern Colombian population. Diabetes Res. Clin. Pract. 72, 170-175 (2006).
32. Radstake TR, Barrera P. Albers JM et al. Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort. Rheumatology (Oxf) 39, 267-273 (2000).
33. Scofield RH, Bruner GR, Kelly JA et al. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 101, 992-997 (2003).
34. Eroglu GE, Kohler PF. Familial systemic lupus erythematosus: the role of genetic and environmental factors. Ann. Rheum. Dis. 61, 29-31 (2002).
35. Laivoranta-Nyman S, Mottonen T, Luukkainen R et al. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann. Rheum. Dis. 59, 173-177 (2000).
36. Anaya JM, Castiblanco J, Tobon GJ et al. Familial clustering of autoimmune diseases in patients with Type 1 diabetes mellitus. J. Autoimmun. 26, 208-214 (2006).
37. Anaya JM, Tobon GJ, Vega P, Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J. Rheumatol. 33, 2227-34 (2006).
38. Baglietto L, Jenkins MA, Severi G et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J. Clin. Epidemiol. 59, 114-124 (2006).
39. Susser E, Susser M. Familial aggregation studies. A note on their epidemiologic properties. Am. J. Epidemiol. 129, 23-30 (1989).
40. Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sjogred's syndrome. J. Rheumatol. 27, 2397-2405 (2000).
41. Fracchia M, Galatola G, Corradi F et al. Coeliac disease associated with Sjogren's syndrome, renal tubular acidosis, primary biliary cirrhosis and autoimmune hyperthyroidism. Dig. Liver Dis. 36, 489-491 (2004).
42. Ittah M, Gottenberg JE, Proust A et al. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome. Genes Immun. 6, 457-458 (2005).
43. Nemes T, Gyodi E, Szanyo F, Rajczy K, Petranyi G. Genetic background of rheumatoid arthritis in connection with a family tree. Orv. Hetil. 142, 2785-2790 (2001).
44. Reveille JD, Wilson RW, Provost TT, Bias WB, Arnett FC. Primary Sjogren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann. Intern. Med. 101, 748-756 (1984).
45. Tanaka A, Igarashi M, Kakinuma M et al. The occurrence ofvarious collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erychematosus. J. Dermatol. 28, 547-553 (2001).
46. Pope JE. Scleroderma overlap syndromes. Curr. Opin. Rheumatol. 14, 704-710 (2002).
47. Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC. Evidence that autoimmunity in man is a Mendelian dominant trait. Am. J. Hum. Genet. 584-602 (1986).
48. Liebman MN. Opening Pandora's box: clinical data and the study of complex diseases. Sci. STKE 130, PE20 (2002).
49. Ahmad YA, Bruce IN. Genetic epidemiology: systemic lupus erythematosus. Arthritis Res. 3, 331-336 (2001).
50. Gregersen PK. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res. 1, 37-44 (1999).
51. Pitkaniemi J, Onkamo P, Tuomilehto J, Arjas E. Increasing incidence of Type 1 diabetes - role for genes? BMC Genet. 5, 5 (2004).
52. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl Acad. Sci. USA 100, 12877-12882 (2003).
53. Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjogren syndrome. How strong is the evidence? Clin. Dev. Immunol. 13, 209-222 (2006).
54. Knip M, Veijola R, Virtanen SM et al. Environmental triggers and determinants of Type 1 diabetes. Diabetes 54(Suppl 2), S125-S136 (2005).
55. Periolo N, Chernavsky AC. Coeliac disease. Autoimmun. Rev. 5, 202-208 (2006).
56. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38, 235-245 (2005).
57. George J, Levy Y, Shoenfeld Y. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand. J. Immunol. 45, 1-6 (1997).
58. Hsu HC, Mountz JD. Origin of late-onset autoimmune disease. Immunol. Allergy Clin. North Am. 23, 65-82, vi (2003).
59. Hafler DA. Multiple sclerosis. J. Clin. Invest. 113, 788-794 (2004).
60. Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad. Med. J. 80, 690-700 (2004).
61. Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J. Rare Dis. 1, 6 (2006).
62. Herrick AL, Worthington J. Genetic epidemiology: systemic sclerosis. Arthritis Res. 4, 165-168 (2002).
63. Jawaheer D, Lum RF, Amos CI, Gregersen PK, Criswell LA. Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum. 50, 736-741 (2004).
64. Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J. Autoimmun. Dis. 2, 1 (2005).
65. Chitnis S, Monteiro J, Glass D et al. The role of X-chromosome inactivation in female predisposition to autoitnmunity. Arthritis Res. 2, 399-406 (2000).
66. Stewart JJ. Theory and treatment of the X-inactivation chimera in female-prevalent autoimmune disease. Arch. Immunol. Ther. Exp. (Warsz) 47, 355-359 (1999).
67. Kast RE. Predominance of autoimmune and rheumatic diseases in females. J. Rheumatol. 4 288-292 (1977).
68. Lockshin MD. Sex ratio and rheumatic disease. Autoimmum. Rev. 1, 162-167 (2002)
69. Invernizzi P Miozzo M, Selmi C et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol. 175, 575-578 (2005).
70. Priori R, Medda E, Conti F et al. Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus 12, 735-740 (2003).
71. Tait KF, Marshall T, Berman J et al. Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository. Diabet. Med. 21, 358-362 (2004)
72. Coyle PK. Gender issues. Neurol. Clin. 23, 39-60, v-vi (2005).
73. Guo SW, Tuomilehto J. Preferential transmission of type 1 diabetes from parents to offspring. fact or artifact? Genet. Epidemiol. 23, 323-334 (2002).
74. Kantarci OH, Barcellos LF. Atkinson EJ. et al. Men transmit MS more often to their children vs women: the Carter effect. Neurology 67, 305-10 (2006).
75. Carter CO. The inheritance ofcongenital pyloric stenosis. Br. Med. Bull. 17, 251-24 (1961).
76. Chakraborty R. The inheritance of pyloric stenosis explained by a multifactorial threshold model with sex dimorphism for liability. Genet. Epidemiol. 3, 1-15 (1986).
77. Horita M, Takahashi N, Seike M, Nasu S, Takaki R. A case of primary biliary cirrhosis associated with Hashimoto's thyroiditis, scleroderma and Sjogrees syndrome. Intern. Med. 31, 418-421 (1992).
78. Madan-Mohan P, Ramesh TC. Multiple autoimmune syndrome. Indian J. Dermatol. Venereol. Leprol. 69, 298-300 (2003).
79. Playas G, Orozco J, Espinoza C, Amavisca R, Carrillo P. Miastenia gravis con poliendocrinopatia autoinmune: presentacion de un caso. Rev. Mex. Neuroci. 3, 79-81 (2002).
80. Sastre-Garriga J, Tintore M, Montalban X. Polyglandular autoimmune syndrome type II and multiple sclerosis. J. Neurol. 248, 330-331 (2001).
81. Donadio V, Cortelli P, Liguori R, Di Stasi V, Montagna P. Multiple sclerosis-like disease in polyglandular autoimmune syndrome. J. Neurol. 248, 61-62 (2001).
82. West M, Jasin HE, Medhekar S. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin. Arthritis Rheum. 35, 344-348 (2006).
83. Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. Isr. Med. Assoc. J. 7, 740-741 (2005).
84. Tirado-Sanchez A, Montes-de-Oca G. Coexistence of bullous pemphigoid, vitiligo, and thyroid disease: a multiple autoimmune syndrome? Dermatol. Online J. 11, 20 (2005).
85. Grandhe NP, Dogra S, Kanwar AJ. Multiple autoimmune syndrome in a patient with pemphigus vulgaris. Acta Derm. Venereol. 85, 91-92 (2005).
86. Muller FB, Groth W, Mahrle G. Multiple autoinumme syndrome. Reynolds-syndrome (acral scleroderma, primary biliary cirrhosis, Sjogren syndrome) associated with the lupus erythematosus/lichen planus overlap syndrome. Hautarzt 55, 465-470 (2004).
87. Marcet B, Sibaud V, Geniaux M, Taieb A. Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?. Ann. Med. Interne (Paris) 153, 349-350 (2002).
88. Coutant G, Bechade D, Mayaudon H, Moulin O, Algayres JP. Association of sarcoidosis and multiple autoimmune syndrome. Ann. Med. Interne (Paris) 151, 519-520 (2000).
89. Klisnick A, Schmidt J, Dupond JL et al. Vitiligo in multiple autoimmune syndrome: a retrospective study of 11 cases and a review of the literature. Rev. Med. Interne 19, 348-352 (1998).
90. Suzuki C, Hirai Y, Terui K et al. Slowly progressive Type 1 diabetes mellitus associated with vitiligo vulgaris, chronic thyroiditis, and pernicious anemia. Intern. Med. 43, 1183-1185 (2004).
91. Christiann F, Rayet P, Aouane F. 2 cases of multiple autoimmune syndrome. Rev. Med. Interne 19, 580-581 (1998).
92. Zonana MF, Reyes E, Weisman AK. Coexistence of four autoimmune diseases in one patient: the kaleidoscope of autoimmunity. J. Clin. Rheumatol. 8, 322-325 (2002).
93. Miyamoto H, Azuma A, Taniguchi Y et al. Interstitial pneumonia complicated by Sjogren's syndrome, Hashimoto's disease, rheumatoid arthritis and primary biliary cirrhosis. Intern. Med. 39, 970-975 (2000).
94. Rahamim-Cohen D, Shoenfeld Y. The mosaic of autoimmunity. A classical case of inhalation ofa polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. Isr. Med. Assoc. J. 3, 381-382 (2001).
95. Sage RE, Forbes IJ. A case of multiple autoimmune disease, lymphoid proliferation and hypogammaglobulinaemia. Blood 31, 536-548 (1968).
96. Bolstad AI, Jonsson R. Genetic aspects of Sjogren's syndrome. Arthritis Res. 4, 353-359 (2002).